United States: protectionist policies under consideration in the pharmaceutical sector
The US Administration has enacted two Executive Orders aimed at making medicines more affordable for citizens and strengthening the domestic pharmaceutical industry. The first measure introduces the principle of the “most favoured nation price” for prescription drugs. According to the Administration, pharmaceutical companies charge significantly lower prices abroad than in the United States in order […]
Read more
